What Are Some Notable Successes of Genomic and Proteomic Analyses in Cancer?
There have been many successes, including:
Targeted Therapies: Development of drugs like imatinib for chronic myeloid leukemia (CML) based on understanding specific genetic alterations. Cancer Subtyping: More precise classification of cancers, such as distinguishing between different subtypes of breast cancer for better-targeted treatments. Immune Checkpoint Inhibitors: Identification of biomarkers that predict response to immunotherapies, significantly impacting treatment strategies.
